The Florey Institute – Introducing the SCN2A Scientist team!

Kris Pierce
January 29, 2019
Blog
0 Comments

Today we are introducing the SCN2A research team at the Florey Institute. The team is lead by Prof Steven Petrou, Director of Florey Institute. The team has been developing a…

Facebook Posts

SCN2A Australia

12 hours ago

Lots of great presentations coming from the American Epilepsy Society.

Below is an interesting poster from Spain presented at #AES2019 showing that adults with intellectual disability and epilepsy were unlikely to have had genetic testing, or other testing done, particularly if they were institutionalised. Shows that there is a long way to go in understanding what severe developmental and epileptic encephalopathies look like later in life.

#SCN2A #CureSCN2A ... See MoreSee Less

Photo

View on Facebook

SCN2A Australia

1 day ago

From XENON PHARMACEUTICALS
AES PRESENTATIONS AND ANNOUNCEMENTS:

Click on link to read about the programs. ... See MoreSee Less

Xenon Pharmaceuticals Provides Updates on Partnered Neurology Pipeline Programs at the 2019 American Epilepsy Society (AES) Annual Meeting | Xenon Pharmaceuticals Inc.

investor.xenon-pharma.com

The Investor Relations website contains information about Xenon Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.

View on Facebook